DepoDur: Dosing

Dose Appropriately for
Effective Relief

Individualized dosing 

As with all opioids, dosing with DepoDur should be adjusted for each patient, considering^15,16:

Age and body mass

Previous opioid experience

Risk factors for respiratory depression

ASA^* physical status

Coadministered medications

Recommended dosing range: 10-15 mg 

For complete dosing information, consult the Dosage and Administration section of the full Prescribing Information.

DepoDur is not intended for intrathecal, intravenous, or intramuscular administration. Administration of DepoDur into the thoracic epidural space or higher has not been evaluated and therefore is not recommended. Once DepoDur has been administered, no other medication should be administered into the epidural space for at least 48 hours.

*American Society of Anesthesiologists.

Important Safety Information

DepoDur is not intended for intrathecal, intravenous, or intramuscular administration. Administration of DepoDur into the thoracic epidural space or higher has not been evaluated and therefore is not recommended. The majority of adverse events were typical opioid-related side effects and would be expected in the surgical populations studied. No statistically significant differences between treatment groups with respect to nausea, pruritus, sedation scores, vomiting episodes, or urinary retention.   

More information on safety page.

Please see full Prescribing Information.